BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Opexa Therapeutics 

2635 N. Crescent Ridge Drive

The Woodlands  Texas  77381  U.S.A.
Phone: 281-272-9331 Fax: 281-272-1088


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Cell Therapy





 Company News
Opexa Therapeutics (OPXA) Invited To Present Biomarker Data From NMO Patients At The American Academy of Neurology 2015 Annual Meeting 4/20/2015 10:56:46 AM
Opexa Therapeutics (OPXA) Announces Completion Of Rights Offering 4/9/2015 9:23:10 AM
Opexa Therapeutics (OPXA) Reminds Shareholders That Rights Offering Expires On April 8, 2015 At 5:00 PM ET 4/6/2015 7:49:28 AM
Opexa Therapeutics (OPXA) Reminds Shareholders That Rights Offering Ownership Date And Time Is Tuesday, March 10, 2015 At 4:00 PM ET 3/10/2015 8:27:50 AM
Opexa Therapeutics (OPXA) Amends Agreement With Merck Serono And Receives Additional $3 Million Payment To Support Ongoing Development Of Tcelna For Multiple Sclerosis 3/9/2015 11:21:37 AM
EMD Serono And Opexa Therapeutics (OPXA) Amend Agreement To Support Ongoing Development Of Tcelna (Imilecleucel-T) For Multiple Sclerosis 3/9/2015 6:51:16 AM
Opexa Therapeutics (OPXA) Announces Record Date And Subscription Price For Rights Offering 2/26/2015 9:45:02 AM
Opexa Therapeutics (OPXA) Reports Year End 2014 Financial Results And Provides Corporate Update 2/23/2015 10:52:38 AM
Opexa Therapeutics (OPXA) Files Registration Statement For Rights Offering 1/28/2015 11:25:21 AM
Opexa Therapeutics (OPXA) Selected As One Of The "Top 10 Advanced Therapy Projects To Watch" 11/18/2014 4:29:53 PM
12345678910...